Aspen has a proud heritage dating back more than 160 years. The Group is committed to sustaining life and promoting healthcare through increasing access to its high quality, effective, affordable medicines and products.

South African-based JSE Limited listed Aspen continues to increase the number of lives benefiting from its products, reaching more than 150 countries across the world. The extensive basket of Aspen products provides treatment for a broad spectrum of acute and chronic conditions experienced throughout all stages of life.

Aspen is represented in South Africa, Australia, Hong Kong, Malaysia, Philippines, Taiwan, Japan, Kenya, Nigeria, Tanzania, Uganda, Ireland, United Arab Emirates, Germany, the Netherlands, Mauritius, Brazil, Mexico, Venezuela and the United States of America. Acquisitions announced in 2013 will further extend the Group’s emerging market presence to the Commonwealth of Independent States, comprising Russia and the former Soviet Republics as well as to Central and Eastern Europe. The Group has 23 manufacturing facilities at 17 sites on 6 continents and approximately 8200 employees.

logo_aspen_nutritionals

 

Latest News

Honorary Doctor of Commerce Degree conferred on Stephen Saad

Port Elizabeth – The Nelson Mandela Metropolitan University (NMMU) today conferred the degree of Doctor of Commerce (honoris causa) on Stephen …

Read more »

Aspen’s half-year revenue increases to R12 billion

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), the ninth largest generic company in the world and Africa’s largest …

Read more »

Aspen’s growth formula

16 January 2014 By : Shaun Harris, Financial Mail On a recent holiday to Disney World with his family, Aspen Pharmacare CEO Stephen …

Read more »

More News

Featured Video

Aspen is now a significant global pharma company, supplying branded and generic pharmaceuticals in more than 150 countries across the world. It was founded by Stephen Saad less than 15 years ago. It has a Market Cap of R125.9 billion, a PE of 32.9 and a dividend yield of 0.5%. David Lerche from Avior Research. Host Bronwyn Nielsen and resident expert Paul Theron from Vestact decide whether Aspen is hot or not.

More Videos

Investor Information

Aspen Group Interim Results for the six months ended 31 December 2013:

Aspen Interim Results Presentation

Download PDF

Aspen Unaudited Interim Results Booklet

Download PDF

Aspen Interim Results Short Form Announcement

Download PDF

Aspen 2013 Reports:

Aspen 2013 Integrated Report

View Online Download PDF

Aspen 2013 Annual Financial Statements

View Online Download PDF

Aspen 2013 Supplementary Documents

View Online

Notice of Annual General Meeting

View Online

Aspen Regional Management Investor Presentation - 11 November 2013

Download PDF

Aspen Port Elizabeth Site Presentation June 2014

Download PDF

Aspen 2013 Fact Sheets:

Aspen Fact Sheet - November 2013

Download PDF

Corporate Brochure - November 2013

View Online Download PDF